A single-Arm, exploratory and prospective study to efficacy and safety of Ruxolitinib in patients with lower and higher risk myelofibrosis
Latest Information Update: 25 Sep 2024
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Myelofibrosis
- Focus Therapeutic Use
- 25 Sep 2024 New trial record